September 14, 2021 12:51 PM Eastern Daylight Time

BUSINESS WIRE

CureApp Hypertonie-Therapeutika-App: Ergebnisse klinischer Tests wurden auf ESC Congress 2021 bekanntgegeben und im European Heart Journal, einer führenden Zeitschrift für kardiovaskuläre Medizin, veröffentlicht

Opens in new window

Download

Full Size JPEG, 1829x471, 202.0 KB
Small JPEG, 480x124, 35.6 KB
Preview JPEG, 144x37, 5.9 KB
Thumbnail JPEG, 120x31, 4.8 KB

Smart Multimedia Gallery

Overview of the digital therapeutic intervention (HERB system) for essential hypertension. (Graphic: Business Wire)

Overview of the digital therapeutic intervention (HERB system) for essential hypertension. (Graphic: Business Wire)

View and Share Photo

Fig 1. Summary of variation from baseline (adjusted mean, 95% confidence interval) and between-group differences in ABPM, home blood pressure, and office blood pressure while sitting at rest at 12 weeks after enrollment (Graphic: Business Wire)

Fig 1. Summary of variation from baseline (adjusted mean, 95% confidence interval) and between-group differences in ABPM, home blood pressure, and office blood pressure while sitting at rest at 12 weeks after enrollment (Graphic: Business Wire)

View and Share Photo

http://www.businesswire.it/multimedia/it/20210914005956/de/5046922/

View and Share Logo

Share

Email

All News | News with Multimedia > Press Release: CureApp Hypertonie-Therapeutika-App: Ergebnisse...